- The U.S. on Oct. 28 purchased 50 million more doses of Pfizer’s COVID-19 vaccine to prepare for pediatric vaccinations.
- The U.S. on Nov. 9 purchased 1.4 million more courses of molnupiravir, the COVID-19 antiviral pill Merck is developing with Ridgeback Biotherapeutics, for roughly $1 billion. The U.S. has now committed to purchase a total of 3.1 million courses of the antiviral for about $2.2 billion.
- The U.S. said Nov. 16 it will buy 10 million courses of Pfizer’s COVID-19 antiviral pill Paxlovid for $5 billion.
- The U.S. on Nov. 17 bought $1 billion worth of COVID-19 monoclonal antibody drug sotrovimab, which is made by GlaxoSmithKline and Vir Biotechnology.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
